Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
38 participants
INTERVENTIONAL
2023-11-29
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives are:
* Identifying links between specific deficits of ASD and difficulties in written production.
* Identifying links between the severity of ASD and difficulties in written production.
The primary evaluation criterion is the quantity of written production, namely the number of words produced in 5 minutes on a text copying task (BHK) and in 15 minutes on each of the two written production tasks (descriptive and persuasive).
The secondary evaluation criteria are:
* Graphomotor indicators of written production (writing speed, pre-writing time, pause time, writing time, handwriting size, results obtained in BHK (number of words produced, letter height, line parallelism, telescoping, ambiguous letters).
* Cognitive and psycholinguistic indicators of written production (presence of titles, presence of paragraphs, number of sentences, number of words per sentence, lexical richness, lexical field, number of action verbs, morphological complexity, number of syntactic markers related to oneself, number of syntactic markers related to others, number of spelling errors, evaluation of the overall quality of the produced text).
* Results obtained in tests (writing habits questionnaire, Autism Diagnostic Observation Scale (second edition), Wechsler Adult Intelligence Scale (fourth edition) - Similarities subtest, Wechsler Adult Intelligence Scale (fourth edition) - Vocabulary subtest, Rey Figure, MASC).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Graphomotor Intervention Program for Handwriting Difficulties Prevention in Preschool Age
NCT03699787
Graphomotor Intervention Program for Handwriting Difficulties Prevention in School-Age
NCT03699800
Telerehabilitation vs. in Presence Rehabilitation of Reading Disorders Using the Rhythmic Reading Training (RRT)
NCT04995471
Comparative Impact of Protocolized Management, Intensive Rehabilitation Versus Long-term Classic Rehabilitation of Dyslexic Children.
NCT05383937
Validation of the Girls Questionnaire for Autism Spectrum Condition in French Langage
NCT06280521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Autism Spectrum Disorder (ASD) is one of the neurodevelopmental disorders (NDD) characterized by persistent deficits in communication and social interaction, and restricted and repetitive patterns of behavior, interests, and activities (DSM-5 diagnostic criteria; American Psychiatric Association, 2013). These symptoms are present from early developmental stages and correspond to neurological conditions characterized by structural and/or functional brain abnormalities.
While diagnosis is typically made in childhood (average age of 4 years (Rogé, 2019)), many adults seek diagnostic evaluation for ASD from autism resource centers (CRA). This is partly due to the diversity of symptoms that can lead to a 'diagnostic odyssey' spanning several years (Rutherford et al., 2016). Even though the dyad identified by DSM-5 allows for precise diagnosis, many other clinical signs can be found in patients with ASD (mood disorders, sleep disorders, impulsivity/hyperactivity, anxiety, motor disorders, language disorders, etc.), which can complicate diagnosis and delay the implementation of early and appropriate intervention.
In this context, an interesting avenue is the study of writing characteristics in patients with ASD. Indeed, several studies show that patients with ASD present deficits in motor skills as well as in several psycholinguistic domains such as grammar, morphology, and phonology (Habib et al., 2019). Furthermore, individuals with ASD may exhibit specific semantic and pragmatic impairments (Bishop, 1989). These findings may provide additional useful clues in a perspective of differential diagnosis and understanding of cognitive functioning.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental arm : Adults with autism spectrum disorder
All of the interventions described below
Cognitive and writing tests
* Wechsler Adult Intelligence Scale - fourth edition (Similarities and Vocabulary subtests)
* MASC (Movie for assessment of social cognition)
* Rey figure
* BHK (Quick Writing Assessment Scale)
* Descriptive text writing
* Persuasive text writing
Control arm : Adults with typical development
All of the interventions described below
Cognitive and writing tests
* Wechsler Adult Intelligence Scale - fourth edition (Similarities and Vocabulary subtests)
* MASC (Movie for assessment of social cognition)
* Rey figure
* BHK (Quick Writing Assessment Scale)
* Descriptive text writing
* Persuasive text writing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive and writing tests
* Wechsler Adult Intelligence Scale - fourth edition (Similarities and Vocabulary subtests)
* MASC (Movie for assessment of social cognition)
* Rey figure
* BHK (Quick Writing Assessment Scale)
* Descriptive text writing
* Persuasive text writing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years Age ≥ 18 years and matching typical adult subjects to ASD individuals in age (plus or minus 5 years), sex, and education level
* The person participating in the research has read, understood, and signed the study consent form
* The person is proficient in the French language
* The person is affiliated with a social security system
Exclusion Criteria
\- Diagnosis of any NDD (ASD, Attention Deficit Hyperactivity Disorder, Specific Learning Disorder, Language Disorder, Coordination Disorder, Intellectual Disorder)
* Refusal of the individual to participate in the study
* Presence of severe visual impairment
* Known pregnancy
* Individual deprived of liberty
* Individual under guardianship or curators
* Presence of concurrent psychotropic medication treatments not stabilized, initiated within the last 2 months: antipsychotics, mood stabilizers, antiepileptics, psychostimulants, antidepressants
* Presence of upper limb motor impairment, with or without devices
* Presence of diagnosed neurological or psychiatric disorders (e.g., Schizophrenia Spectrum Disorder or other psychotic disorders), presence of a general or metabolic pathology known to have an impact on cognitive efficiency and/or motor skills of the individual (e.g., Epilepsy, Tics and Tourette Syndrome, Neuro-muscular Syndrome, Metabolic Neurological Syndromes, neoplasms)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Poitiers
OTHER
Centre Hospitalier de Niort
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Evan Launay
Psychologist and PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Evan E Launay, Mr
Role: PRINCIPAL_INVESTIGATOR
Hospital Center of Niort (France)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de Niort
Niort, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI-2023-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.